BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dong M, Zhou JP, Zhang H, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(18): 2744-2747 [PMID: 15884114 DOI: 10.3748/wjg.v11.i18.2744]
URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2744.htm
Number Citing Articles
1
Sridharan Jeyamohan, Rajesh Kannan Moorthy, Mahesh Kumar Kannan, Antony Joseph Velanganni Arockiam. Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancerBiotechnology Letters 2016; 38(8): 1251 doi: 10.1007/s10529-016-2102-7
2
Parisa Bazsefidpar, Shabnaz Koochakkhani, Behnaz Rahnama Inchehsablagh, Ebrahim Eftekhar, Elahe Aliasgari. Tin (IV) oxide (SnO2) nanoparticles inhibit the viability of cervical cancer HeLa cells through induction of apoptosisJournal of Reports in Pharmaceutical Sciences 2021; 10(2): 225 doi: 10.4103/jrptps.JRPTPS_109_20
3
Richard A. Smith, Jane V. Butler, John P. Neoptolemos. Patient Surveillance After Cancer Treatment2013; : 129 doi: 10.1007/978-1-60327-969-7_24
4
Giuseppe Tonini, Francesco Pantano, Bruno Vincenzi, Armando Gabbrielli, Roberto Coppola, Daniele Santini. Molecular prognostic factors in patients with pancreatic cancerExpert Opinion on Therapeutic Targets 2007; 11(12): 1553 doi: 10.1517/14728222.11.12.1553
5
Daniel Ansari, William Torén, Qimin Zhou, Dingyuan Hu, Roland Andersson. Proteomic and genomic profiling of pancreatic cancerCell Biology and Toxicology 2019; 35(4): 333 doi: 10.1007/s10565-019-09465-9
6
Yan Shen, Minxia Cai, Weiliang Xia, Junwei Liu, Qiyi Zhang, Haiyang Xie, Chen Wang, Xiaohui Wang, Shusen Zheng. FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cellsCancer Letters 2007; 254(2): 288 doi: 10.1016/j.canlet.2007.03.013
7
R A Smith, J Tang, C Tudur-Smith, J P Neoptolemos, P Ghaneh. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancerBritish Journal of Cancer 2011; 104(9): 1440 doi: 10.1038/bjc.2011.110
8
Randall J Kimple, Suzanne Russo, Arta Monjazeb, A William Blackstock. The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancerExpert Review of Anticancer Therapy 2012; 12(4): 469 doi: 10.1586/era.12.18
9
Cuiyue Wang, Zhen Feng, Kaitong Jiang, Xiuli Zuo. [ARTICLE WITHDRAWN] Upregulation of MicroRNA-935 Promotes the Malignant Behaviors of Pancreatic Carcinoma PANC-1 Cells via Targeting Inositol Polyphosphate 4-Phosphatase Type I Gene (INPP4A)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(4): 559 doi: 10.3727/096504016X14759554689565
10
Filippo Pietrantonio, Pamela Biondani, Elisa Ciurlia, Giuseppe Fanetti, Anna Tessari, Gaia Bertarelli, Ilaria Bossi, Valeria Musella, Flavia Melotti, Maria Di Bartolomeo, Francesca Valvo, Alessandro Pellegrinelli, Massimo Milione, Federica Perrone, Filippo de Braud. Role of BAX for outcome prediction in gastrointestinal malignanciesMedical Oncology 2013; 30(3) doi: 10.1007/s12032-013-0610-z
11
D Ansari, A Rosendahl, J Elebro, R Andersson. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancerBritish Journal of Surgery 2011; 98(8): 1041 doi: 10.1002/bjs.7574
12
Nigel B. Jamieson, C. Ross Carter, Colin J. McKay, Karin A. Oien. Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysisClinical Cancer Research 2011; 17(10): 3316 doi: 10.1158/1078-0432.CCR-10-3284